Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Trial Identifier: D7060C00002
Sponsor: AstraZeneca
NCTID:: NCT05714254
Start Date: December 2022
Primary Completion Date: December 2023
Study Completion Date: December 2023
Condition: Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation

Trial Locations

Country Location
DE Berlin, DE, 10117